nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—Topoisomerase Inhibitors—Idarubicin—breast cancer	0.166	0.366	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Irinotecan—breast cancer	0.141	0.311	CiPCiCtD
Mitoxantrone—PIM1—breast cancer	0.116	0.497	CbGaD
Mitoxantrone—Topoisomerase Inhibitors—Epirubicin—breast cancer	0.0764	0.168	CiPCiCtD
Mitoxantrone—Topoisomerase Inhibitors—Doxorubicin—breast cancer	0.0707	0.155	CiPCiCtD
Mitoxantrone—ABCC1—breast cancer	0.033	0.142	CbGaD
Mitoxantrone—TOP2A—Idarubicin—breast cancer	0.0275	0.147	CbGbCtD
Mitoxantrone—TOP2A—breast cancer	0.0254	0.109	CbGaD
Mitoxantrone—CYP1B1—breast cancer	0.0252	0.108	CbGaD
Mitoxantrone—ABCG2—breast cancer	0.0174	0.0748	CbGaD
Mitoxantrone—ABCC1—Idarubicin—breast cancer	0.0153	0.0815	CbGbCtD
Mitoxantrone—TOP2A—Epirubicin—breast cancer	0.00958	0.0512	CbGbCtD
Mitoxantrone—CYP1B1—Tamoxifen—breast cancer	0.00947	0.0506	CbGbCtD
Mitoxantrone—CYP3A4—breast cancer	0.00869	0.0374	CbGaD
Mitoxantrone—CYP1B1—Paclitaxel—breast cancer	0.00737	0.0394	CbGbCtD
Mitoxantrone—ABCB1—breast cancer	0.00723	0.0311	CbGaD
Mitoxantrone—CYP1B1—Docetaxel—breast cancer	0.00533	0.0285	CbGbCtD
Mitoxantrone—ABCC1—Epirubicin—breast cancer	0.00531	0.0284	CbGbCtD
Mitoxantrone—ABCC1—Paclitaxel—breast cancer	0.00524	0.028	CbGbCtD
Mitoxantrone—ABCC1—Irinotecan—breast cancer	0.00517	0.0276	CbGbCtD
Mitoxantrone—TOP2A—Doxorubicin—breast cancer	0.00509	0.0272	CbGbCtD
Mitoxantrone—ABCC1—Vinblastine—breast cancer	0.00459	0.0245	CbGbCtD
Mitoxantrone—ABCG2—Tamoxifen—breast cancer	0.0045	0.0241	CbGbCtD
Mitoxantrone—ABCB1—Toremifene—breast cancer	0.00444	0.0237	CbGbCtD
Mitoxantrone—CYP1B1—Doxorubicin—breast cancer	0.00397	0.0212	CbGbCtD
Mitoxantrone—CYP3A4—Exemestane—breast cancer	0.00384	0.0205	CbGbCtD
Mitoxantrone—ABCC1—Docetaxel—breast cancer	0.00379	0.0202	CbGbCtD
Mitoxantrone—ABCG2—Paclitaxel—breast cancer	0.0035	0.0187	CbGbCtD
Mitoxantrone—ABCG2—Irinotecan—breast cancer	0.00346	0.0185	CbGbCtD
Mitoxantrone—ABCG2—Fluorouracil—breast cancer	0.00332	0.0177	CbGbCtD
Mitoxantrone—ABCG2—Carboplatin—breast cancer	0.0033	0.0176	CbGbCtD
Mitoxantrone—CYP3A4—Letrozole—breast cancer	0.00327	0.0175	CbGbCtD
Mitoxantrone—ABCB1—Lapatinib—breast cancer	0.00324	0.0173	CbGbCtD
Mitoxantrone—CYP2E1—Tamoxifen—breast cancer	0.00321	0.0172	CbGbCtD
Mitoxantrone—CYP3A4—Anastrozole—breast cancer	0.00291	0.0156	CbGbCtD
Mitoxantrone—ABCC1—Doxorubicin—breast cancer	0.00282	0.0151	CbGbCtD
Mitoxantrone—ABCC1—Methotrexate—breast cancer	0.00273	0.0146	CbGbCtD
Mitoxantrone—CYP3A4—Toremifene—breast cancer	0.00266	0.0142	CbGbCtD
Mitoxantrone—ABCG2—Docetaxel—breast cancer	0.00253	0.0135	CbGbCtD
Mitoxantrone—CYP3A4—Fulvestrant—breast cancer	0.00247	0.0132	CbGbCtD
Mitoxantrone—CYP3A4—Thiotepa—breast cancer	0.00221	0.0118	CbGbCtD
Mitoxantrone—CYP3A4—Ixabepilone—breast cancer	0.00202	0.0108	CbGbCtD
Mitoxantrone—CYP3A4—Lapatinib—breast cancer	0.00194	0.0104	CbGbCtD
Mitoxantrone—ABCG2—Doxorubicin—breast cancer	0.00189	0.0101	CbGbCtD
Mitoxantrone—ABCG2—Methotrexate—breast cancer	0.00183	0.00977	CbGbCtD
Mitoxantrone—ABCB1—Vinorelbine—breast cancer	0.0018	0.00961	CbGbCtD
Mitoxantrone—ABCB1—Tamoxifen—breast cancer	0.00162	0.00867	CbGbCtD
Mitoxantrone—CYP3A4—Raloxifene—breast cancer	0.00147	0.00787	CbGbCtD
Mitoxantrone—ABCB1—Gemcitabine—breast cancer	0.0014	0.00747	CbGbCtD
Mitoxantrone—ABCB1—Paclitaxel—breast cancer	0.00126	0.00675	CbGbCtD
Mitoxantrone—ABCB1—Irinotecan—breast cancer	0.00125	0.00666	CbGbCtD
Mitoxantrone—ABCB1—Vinblastine—breast cancer	0.00111	0.00592	CbGbCtD
Mitoxantrone—CYP3A4—Vinorelbine—breast cancer	0.00108	0.00576	CbGbCtD
Mitoxantrone—CYP3A4—Tamoxifen—breast cancer	0.000972	0.0052	CbGbCtD
Mitoxantrone—ABCB1—Docetaxel—breast cancer	0.000913	0.00488	CbGbCtD
Mitoxantrone—PIM1—mammary gland—breast cancer	0.000847	0.0503	CbGeAlD
Mitoxantrone—BTK—nipple—breast cancer	0.000809	0.048	CbGeAlD
Mitoxantrone—CYP3A4—Paclitaxel—breast cancer	0.000757	0.00404	CbGbCtD
Mitoxantrone—CYP3A4—Irinotecan—breast cancer	0.000747	0.00399	CbGbCtD
Mitoxantrone—PIM1—nipple—breast cancer	0.000701	0.0416	CbGeAlD
Mitoxantrone—ABCB1—Doxorubicin—breast cancer	0.000681	0.00364	CbGbCtD
Mitoxantrone—CYP3A4—Vinblastine—breast cancer	0.000664	0.00355	CbGbCtD
Mitoxantrone—ABCB1—Methotrexate—breast cancer	0.00066	0.00352	CbGbCtD
Mitoxantrone—CYP3A4—Docetaxel—breast cancer	0.000547	0.00292	CbGbCtD
Mitoxantrone—PIM1—skin of body—breast cancer	0.000449	0.0266	CbGeAlD
Mitoxantrone—BTK—pituitary gland—breast cancer	0.000442	0.0262	CbGeAlD
Mitoxantrone—BTK—adipose tissue—breast cancer	0.00044	0.0261	CbGeAlD
Mitoxantrone—PIM1—endometrium—breast cancer	0.000423	0.0251	CbGeAlD
Mitoxantrone—TOP2A—nipple—breast cancer	0.000411	0.0244	CbGeAlD
Mitoxantrone—CYP3A4—Doxorubicin—breast cancer	0.000408	0.00218	CbGbCtD
Mitoxantrone—BTK—adrenal gland—breast cancer	0.000395	0.0234	CbGeAlD
Mitoxantrone—PIM1—uterus—breast cancer	0.00039	0.0232	CbGeAlD
Mitoxantrone—PIM1—pituitary gland—breast cancer	0.000383	0.0227	CbGeAlD
Mitoxantrone—BTK—bone marrow—breast cancer	0.000382	0.0227	CbGeAlD
Mitoxantrone—PIM1—adipose tissue—breast cancer	0.000381	0.0226	CbGeAlD
Mitoxantrone—SLC47A1—nipple—breast cancer	0.000375	0.0223	CbGeAlD
Mitoxantrone—BTK—female gonad—breast cancer	0.000368	0.0219	CbGeAlD
Mitoxantrone—PIM1—female reproductive system—breast cancer	0.00035	0.0208	CbGeAlD
Mitoxantrone—PIM1—adrenal gland—breast cancer	0.000342	0.0203	CbGeAlD
Mitoxantrone—CYP1B1—mammary gland—breast cancer	0.000333	0.0198	CbGeAlD
Mitoxantrone—PIM1—bone marrow—breast cancer	0.000331	0.0196	CbGeAlD
Mitoxantrone—PIM1—female gonad—breast cancer	0.000319	0.0189	CbGeAlD
Mitoxantrone—PIM1—endocrine gland—breast cancer	0.000297	0.0176	CbGeAlD
Mitoxantrone—TOP2A—endometrium—breast cancer	0.000248	0.0147	CbGeAlD
Mitoxantrone—ABCC1—nipple—breast cancer	0.000247	0.0147	CbGeAlD
Mitoxantrone—BTK—lymph node—breast cancer	0.000237	0.0141	CbGeAlD
Mitoxantrone—TOP2A—uterus—breast cancer	0.000229	0.0136	CbGeAlD
Mitoxantrone—SLC47A1—endometrium—breast cancer	0.000227	0.0135	CbGeAlD
Mitoxantrone—TOP2A—adipose tissue—breast cancer	0.000224	0.0133	CbGeAlD
Mitoxantrone—SLC47A1—uterus—breast cancer	0.000209	0.0124	CbGeAlD
Mitoxantrone—SLC47A1—pituitary gland—breast cancer	0.000205	0.0122	CbGeAlD
Mitoxantrone—PIM1—lymph node—breast cancer	0.000205	0.0122	CbGeAlD
Mitoxantrone—SLC47A1—adipose tissue—breast cancer	0.000204	0.0121	CbGeAlD
Mitoxantrone—TOP2A—adrenal gland—breast cancer	0.000201	0.0119	CbGeAlD
Mitoxantrone—TOP2A—bone marrow—breast cancer	0.000194	0.0115	CbGeAlD
Mitoxantrone—SLC47A1—female reproductive system—breast cancer	0.000188	0.0112	CbGeAlD
Mitoxantrone—TOP2A—female gonad—breast cancer	0.000187	0.0111	CbGeAlD
Mitoxantrone—SLC47A1—adrenal gland—breast cancer	0.000183	0.0109	CbGeAlD
Mitoxantrone—CYP1B1—skin of body—breast cancer	0.000176	0.0105	CbGeAlD
Mitoxantrone—SLC47A1—female gonad—breast cancer	0.000171	0.0101	CbGeAlD
Mitoxantrone—SLC47A1—endocrine gland—breast cancer	0.000159	0.00944	CbGeAlD
Mitoxantrone—CYP1B1—uterus—breast cancer	0.000153	0.00909	CbGeAlD
Mitoxantrone—CYP1B1—pituitary gland—breast cancer	0.00015	0.00893	CbGeAlD
Mitoxantrone—CYP1B1—adipose tissue—breast cancer	0.00015	0.00889	CbGeAlD
Mitoxantrone—ABCC1—endometrium—breast cancer	0.000149	0.00887	CbGeAlD
Mitoxantrone—ABCC1—uterus—breast cancer	0.000138	0.00818	CbGeAlD
Mitoxantrone—CYP1B1—female reproductive system—breast cancer	0.000138	0.00817	CbGeAlD
Mitoxantrone—ABCC1—pituitary gland—breast cancer	0.000135	0.00803	CbGeAlD
Mitoxantrone—ABCC1—adipose tissue—breast cancer	0.000135	0.008	CbGeAlD
Mitoxantrone—CYP1B1—adrenal gland—breast cancer	0.000134	0.00798	CbGeAlD
Mitoxantrone—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.000128	0.121	CbGdCrCtD
Mitoxantrone—TOP2A—Gefitinib—Lapatinib—breast cancer	0.000126	0.118	CbGdCrCtD
Mitoxantrone—CYP1B1—female gonad—breast cancer	0.000125	0.00744	CbGeAlD
Mitoxantrone—ABCG2—endometrium—breast cancer	0.000124	0.00735	CbGeAlD
Mitoxantrone—ABCC1—adrenal gland—breast cancer	0.000121	0.00717	CbGeAlD
Mitoxantrone—TOP2A—lymph node—breast cancer	0.00012	0.00714	CbGeAlD
Mitoxantrone—CYP1B1—endocrine gland—breast cancer	0.000116	0.00692	CbGeAlD
Mitoxantrone—ABCG2—uterus—breast cancer	0.000114	0.00677	CbGeAlD
Mitoxantrone—ABCC1—female gonad—breast cancer	0.000113	0.00669	CbGeAlD
Mitoxantrone—ABCG2—pituitary gland—breast cancer	0.000112	0.00665	CbGeAlD
Mitoxantrone—ABCG2—adipose tissue—breast cancer	0.000111	0.00662	CbGeAlD
Mitoxantrone—SLC47A1—lymph node—breast cancer	0.00011	0.00652	CbGeAlD
Mitoxantrone—ABCG2—adrenal gland—breast cancer	0.0001	0.00594	CbGeAlD
Mitoxantrone—ABCG2—bone marrow—breast cancer	9.67e-05	0.00575	CbGeAlD
Mitoxantrone—ABCG2—female gonad—breast cancer	9.32e-05	0.00554	CbGeAlD
Mitoxantrone—TOP2A—Topotecan—Irinotecan—breast cancer	9.11e-05	0.0857	CbGdCrCtD
Mitoxantrone—CYP2E1—female reproductive system—breast cancer	8.87e-05	0.00527	CbGeAlD
Mitoxantrone—CYP2E1—adrenal gland—breast cancer	8.66e-05	0.00514	CbGeAlD
Mitoxantrone—ABCB1—embryo—breast cancer	8.34e-05	0.00495	CbGeAlD
Mitoxantrone—TOP2A—Vindesine—Vinorelbine—breast cancer	8.14e-05	0.0766	CbGdCrCtD
Mitoxantrone—CYP1B1—lymph node—breast cancer	8.05e-05	0.00478	CbGeAlD
Mitoxantrone—CYP2E1—endocrine gland—breast cancer	7.51e-05	0.00446	CbGeAlD
Mitoxantrone—ABCC1—lymph node—breast cancer	7.24e-05	0.0043	CbGeAlD
Mitoxantrone—CYP3A4—female reproductive system—breast cancer	7.14e-05	0.00424	CbGeAlD
Mitoxantrone—ABCB1—epithelium—breast cancer	6.8e-05	0.00404	CbGeAlD
Mitoxantrone—TOP2A—Vindesine—Vinblastine—breast cancer	6.51e-05	0.0613	CbGdCrCtD
Mitoxantrone—TOP2A—Paclitaxel—Docetaxel—breast cancer	6.39e-05	0.0601	CbGdCrCtD
Mitoxantrone—ABCB1—endometrium—breast cancer	6.1e-05	0.00362	CbGeAlD
Mitoxantrone—CYP3A4—endocrine gland—breast cancer	6.04e-05	0.00359	CbGeAlD
Mitoxantrone—ABCG2—lymph node—breast cancer	5.99e-05	0.00356	CbGeAlD
Mitoxantrone—ABCB1—uterus—breast cancer	5.62e-05	0.00334	CbGeAlD
Mitoxantrone—ABCB1—pituitary gland—breast cancer	5.52e-05	0.00328	CbGeAlD
Mitoxantrone—ABCB1—adipose tissue—breast cancer	5.5e-05	0.00327	CbGeAlD
Mitoxantrone—ABCB1—female reproductive system—breast cancer	5.05e-05	0.003	CbGeAlD
Mitoxantrone—ABCB1—adrenal gland—breast cancer	4.93e-05	0.00293	CbGeAlD
Mitoxantrone—ABCB1—bone marrow—breast cancer	4.77e-05	0.00283	CbGeAlD
Mitoxantrone—TOP2A—Daunorubicin—Idarubicin—breast cancer	4.66e-05	0.0439	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Idarubicin—breast cancer	4.66e-05	0.0439	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Idarubicin—breast cancer	4.66e-05	0.0439	CbGdCrCtD
Mitoxantrone—ABCB1—female gonad—breast cancer	4.6e-05	0.00273	CbGeAlD
Mitoxantrone—TOP2A—Vincristine—Vinorelbine—breast cancer	4.39e-05	0.0413	CbGdCrCtD
Mitoxantrone—ABCB1—endocrine gland—breast cancer	4.28e-05	0.00254	CbGeAlD
Mitoxantrone—TOP2A—Vinorelbine—Vinblastine—breast cancer	4.11e-05	0.0387	CbGdCrCtD
Mitoxantrone—TOP2A—Vinblastine—Vinorelbine—breast cancer	3.53e-05	0.0333	CbGdCrCtD
Mitoxantrone—TOP2A—Vincristine—Vinblastine—breast cancer	3.51e-05	0.0331	CbGdCrCtD
Mitoxantrone—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	2.96e-05	0.0278	CbGdCrCtD
Mitoxantrone—ABCB1—lymph node—breast cancer	2.96e-05	0.00176	CbGeAlD
Mitoxantrone—TOP2A—Cytarabine—Gemcitabine—breast cancer	2.31e-05	0.0217	CbGdCrCtD
Mitoxantrone—TOP2A—Doxorubicin—Epirubicin—breast cancer	2.14e-05	0.0201	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Epirubicin—breast cancer	2.14e-05	0.0201	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Epirubicin—breast cancer	2.14e-05	0.0201	CbGdCrCtD
Mitoxantrone—TOP2A—Epirubicin—Doxorubicin—breast cancer	1.98e-05	0.0186	CbGdCrCtD
Mitoxantrone—TOP2A—Idarubicin—Doxorubicin—breast cancer	1.98e-05	0.0186	CbGdCrCtD
Mitoxantrone—TOP2A—Daunorubicin—Doxorubicin—breast cancer	1.98e-05	0.0186	CbGdCrCtD
Mitoxantrone—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	1.93e-05	0.0181	CbGdCrCtD
Mitoxantrone—TOP2A—Azacitidine—Gemcitabine—breast cancer	1.66e-05	0.0156	CbGdCrCtD
Mitoxantrone—Gastrointestinal pain—Paclitaxel—breast cancer	1.06e-05	0.000159	CcSEcCtD
Mitoxantrone—Diarrhoea—Gemcitabine—breast cancer	1.06e-05	0.000159	CcSEcCtD
Mitoxantrone—Renal failure—Doxorubicin—breast cancer	1.05e-05	0.000159	CcSEcCtD
Mitoxantrone—Infection—Capecitabine—breast cancer	1.05e-05	0.000159	CcSEcCtD
Mitoxantrone—Haemoglobin—Epirubicin—breast cancer	1.04e-05	0.000158	CcSEcCtD
Mitoxantrone—Stomatitis—Doxorubicin—breast cancer	1.04e-05	0.000158	CcSEcCtD
Mitoxantrone—Jaundice—Doxorubicin—breast cancer	1.04e-05	0.000158	CcSEcCtD
Mitoxantrone—Anorexia—Docetaxel—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Shock—Capecitabine—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Rhinitis—Epirubicin—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Urinary tract infection—Doxorubicin—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Conjunctivitis—Doxorubicin—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Haemorrhage—Epirubicin—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Hepatitis—Epirubicin—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Diarrhoea—Fluorouracil—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Capecitabine—breast cancer	1.04e-05	0.000157	CcSEcCtD
Mitoxantrone—Tachycardia—Capecitabine—breast cancer	1.03e-05	0.000156	CcSEcCtD
Mitoxantrone—Pharyngitis—Epirubicin—breast cancer	1.03e-05	0.000156	CcSEcCtD
Mitoxantrone—Skin disorder—Capecitabine—breast cancer	1.03e-05	0.000155	CcSEcCtD
Mitoxantrone—Sweating—Doxorubicin—breast cancer	1.03e-05	0.000155	CcSEcCtD
Mitoxantrone—Urticaria—Paclitaxel—breast cancer	1.03e-05	0.000155	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Capecitabine—breast cancer	1.02e-05	0.000155	CcSEcCtD
Mitoxantrone—Hypotension—Docetaxel—breast cancer	1.02e-05	0.000154	CcSEcCtD
Mitoxantrone—Haematuria—Doxorubicin—breast cancer	1.02e-05	0.000154	CcSEcCtD
Mitoxantrone—Abdominal pain—Paclitaxel—breast cancer	1.02e-05	0.000154	CcSEcCtD
Mitoxantrone—Body temperature increased—Paclitaxel—breast cancer	1.02e-05	0.000154	CcSEcCtD
Mitoxantrone—Anorexia—Capecitabine—breast cancer	1.01e-05	0.000152	CcSEcCtD
Mitoxantrone—Vomiting—Irinotecan—breast cancer	1.01e-05	0.000152	CcSEcCtD
Mitoxantrone—Sinusitis—Doxorubicin—breast cancer	1.01e-05	0.000152	CcSEcCtD
Mitoxantrone—Agranulocytosis—Doxorubicin—breast cancer	1e-05	0.000151	CcSEcCtD
Mitoxantrone—Rash—Irinotecan—breast cancer	9.99e-06	0.000151	CcSEcCtD
Mitoxantrone—Dermatitis—Irinotecan—breast cancer	9.98e-06	0.000151	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Docetaxel—breast cancer	9.98e-06	0.000151	CcSEcCtD
Mitoxantrone—Chills—Methotrexate—breast cancer	9.97e-06	0.00015	CcSEcCtD
Mitoxantrone—Headache—Irinotecan—breast cancer	9.92e-06	0.00015	CcSEcCtD
Mitoxantrone—Hypotension—Capecitabine—breast cancer	9.91e-06	0.000149	CcSEcCtD
Mitoxantrone—Paraesthesia—Docetaxel—breast cancer	9.83e-06	0.000148	CcSEcCtD
Mitoxantrone—Alopecia—Methotrexate—breast cancer	9.81e-06	0.000148	CcSEcCtD
Mitoxantrone—Vomiting—Gemcitabine—breast cancer	9.81e-06	0.000148	CcSEcCtD
Mitoxantrone—Bradycardia—Doxorubicin—breast cancer	9.79e-06	0.000148	CcSEcCtD
Mitoxantrone—Dyspnoea—Docetaxel—breast cancer	9.76e-06	0.000147	CcSEcCtD
Mitoxantrone—Somnolence—Docetaxel—breast cancer	9.73e-06	0.000147	CcSEcCtD
Mitoxantrone—Rash—Gemcitabine—breast cancer	9.73e-06	0.000147	CcSEcCtD
Mitoxantrone—Dermatitis—Gemcitabine—breast cancer	9.72e-06	0.000147	CcSEcCtD
Mitoxantrone—Erythema—Methotrexate—breast cancer	9.67e-06	0.000146	CcSEcCtD
Mitoxantrone—Haemoglobin—Doxorubicin—breast cancer	9.67e-06	0.000146	CcSEcCtD
Mitoxantrone—Headache—Gemcitabine—breast cancer	9.67e-06	0.000146	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Capecitabine—breast cancer	9.66e-06	0.000146	CcSEcCtD
Mitoxantrone—Vomiting—Fluorouracil—breast cancer	9.64e-06	0.000146	CcSEcCtD
Mitoxantrone—Rhinitis—Doxorubicin—breast cancer	9.64e-06	0.000145	CcSEcCtD
Mitoxantrone—Dyspepsia—Docetaxel—breast cancer	9.64e-06	0.000145	CcSEcCtD
Mitoxantrone—Haemorrhage—Doxorubicin—breast cancer	9.62e-06	0.000145	CcSEcCtD
Mitoxantrone—Hepatitis—Doxorubicin—breast cancer	9.62e-06	0.000145	CcSEcCtD
Mitoxantrone—Rash—Fluorouracil—breast cancer	9.56e-06	0.000144	CcSEcCtD
Mitoxantrone—Dermatitis—Fluorouracil—breast cancer	9.56e-06	0.000144	CcSEcCtD
Mitoxantrone—Pharyngitis—Doxorubicin—breast cancer	9.55e-06	0.000144	CcSEcCtD
Mitoxantrone—Paraesthesia—Capecitabine—breast cancer	9.52e-06	0.000144	CcSEcCtD
Mitoxantrone—Decreased appetite—Docetaxel—breast cancer	9.52e-06	0.000144	CcSEcCtD
Mitoxantrone—Hypersensitivity—Paclitaxel—breast cancer	9.52e-06	0.000144	CcSEcCtD
Mitoxantrone—Headache—Fluorouracil—breast cancer	9.5e-06	0.000143	CcSEcCtD
Mitoxantrone—Dysgeusia—Methotrexate—breast cancer	9.47e-06	0.000143	CcSEcCtD
Mitoxantrone—Dyspnoea—Capecitabine—breast cancer	9.45e-06	0.000143	CcSEcCtD
Mitoxantrone—Fatigue—Docetaxel—breast cancer	9.44e-06	0.000142	CcSEcCtD
Mitoxantrone—Nausea—Irinotecan—breast cancer	9.41e-06	0.000142	CcSEcCtD
Mitoxantrone—Constipation—Docetaxel—breast cancer	9.36e-06	0.000141	CcSEcCtD
Mitoxantrone—Pain—Docetaxel—breast cancer	9.36e-06	0.000141	CcSEcCtD
Mitoxantrone—Back pain—Methotrexate—breast cancer	9.35e-06	0.000141	CcSEcCtD
Mitoxantrone—Dyspepsia—Capecitabine—breast cancer	9.33e-06	0.000141	CcSEcCtD
Mitoxantrone—Chills—Epirubicin—breast cancer	9.33e-06	0.000141	CcSEcCtD
Mitoxantrone—Arrhythmia—Epirubicin—breast cancer	9.29e-06	0.00014	CcSEcCtD
Mitoxantrone—Asthenia—Paclitaxel—breast cancer	9.27e-06	0.00014	CcSEcCtD
Mitoxantrone—Decreased appetite—Capecitabine—breast cancer	9.21e-06	0.000139	CcSEcCtD
Mitoxantrone—Alopecia—Epirubicin—breast cancer	9.19e-06	0.000139	CcSEcCtD
Mitoxantrone—Nausea—Gemcitabine—breast cancer	9.16e-06	0.000138	CcSEcCtD
Mitoxantrone—Fatigue—Capecitabine—breast cancer	9.14e-06	0.000138	CcSEcCtD
Mitoxantrone—Vision blurred—Methotrexate—breast cancer	9.11e-06	0.000137	CcSEcCtD
Mitoxantrone—Pain—Capecitabine—breast cancer	9.06e-06	0.000137	CcSEcCtD
Mitoxantrone—Constipation—Capecitabine—breast cancer	9.06e-06	0.000137	CcSEcCtD
Mitoxantrone—Erythema—Epirubicin—breast cancer	9.05e-06	0.000137	CcSEcCtD
Mitoxantrone—Feeling abnormal—Docetaxel—breast cancer	9.02e-06	0.000136	CcSEcCtD
Mitoxantrone—Nausea—Fluorouracil—breast cancer	9.01e-06	0.000136	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Methotrexate—breast cancer	8.97e-06	0.000135	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Docetaxel—breast cancer	8.95e-06	0.000135	CcSEcCtD
Mitoxantrone—Anaemia—Methotrexate—breast cancer	8.94e-06	0.000135	CcSEcCtD
Mitoxantrone—Dysgeusia—Epirubicin—breast cancer	8.86e-06	0.000134	CcSEcCtD
Mitoxantrone—Diarrhoea—Paclitaxel—breast cancer	8.84e-06	0.000133	CcSEcCtD
Mitoxantrone—Back pain—Epirubicin—breast cancer	8.75e-06	0.000132	CcSEcCtD
Mitoxantrone—Feeling abnormal—Capecitabine—breast cancer	8.74e-06	0.000132	CcSEcCtD
Mitoxantrone—Malaise—Methotrexate—breast cancer	8.72e-06	0.000132	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Capecitabine—breast cancer	8.67e-06	0.000131	CcSEcCtD
Mitoxantrone—Body temperature increased—Docetaxel—breast cancer	8.66e-06	0.000131	CcSEcCtD
Mitoxantrone—Abdominal pain—Docetaxel—breast cancer	8.66e-06	0.000131	CcSEcCtD
Mitoxantrone—Leukopenia—Methotrexate—breast cancer	8.65e-06	0.000131	CcSEcCtD
Mitoxantrone—Chills—Doxorubicin—breast cancer	8.63e-06	0.00013	CcSEcCtD
Mitoxantrone—Arrhythmia—Doxorubicin—breast cancer	8.59e-06	0.00013	CcSEcCtD
Mitoxantrone—Vision blurred—Epirubicin—breast cancer	8.53e-06	0.000129	CcSEcCtD
Mitoxantrone—Alopecia—Doxorubicin—breast cancer	8.5e-06	0.000128	CcSEcCtD
Mitoxantrone—Cough—Methotrexate—breast cancer	8.44e-06	0.000127	CcSEcCtD
Mitoxantrone—Urticaria—Capecitabine—breast cancer	8.42e-06	0.000127	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Epirubicin—breast cancer	8.4e-06	0.000127	CcSEcCtD
Mitoxantrone—Body temperature increased—Capecitabine—breast cancer	8.38e-06	0.000126	CcSEcCtD
Mitoxantrone—Abdominal pain—Capecitabine—breast cancer	8.38e-06	0.000126	CcSEcCtD
Mitoxantrone—Convulsion—Methotrexate—breast cancer	8.38e-06	0.000126	CcSEcCtD
Mitoxantrone—Erythema—Doxorubicin—breast cancer	8.37e-06	0.000126	CcSEcCtD
Mitoxantrone—Anaemia—Epirubicin—breast cancer	8.36e-06	0.000126	CcSEcCtD
Mitoxantrone—Chest pain—Methotrexate—breast cancer	8.23e-06	0.000124	CcSEcCtD
Mitoxantrone—Arthralgia—Methotrexate—breast cancer	8.23e-06	0.000124	CcSEcCtD
Mitoxantrone—Myalgia—Methotrexate—breast cancer	8.23e-06	0.000124	CcSEcCtD
Mitoxantrone—Vomiting—Paclitaxel—breast cancer	8.21e-06	0.000124	CcSEcCtD
Mitoxantrone—Dysgeusia—Doxorubicin—breast cancer	8.2e-06	0.000124	CcSEcCtD
Mitoxantrone—Malaise—Epirubicin—breast cancer	8.16e-06	0.000123	CcSEcCtD
Mitoxantrone—Rash—Paclitaxel—breast cancer	8.14e-06	0.000123	CcSEcCtD
Mitoxantrone—Dermatitis—Paclitaxel—breast cancer	8.14e-06	0.000123	CcSEcCtD
Mitoxantrone—Discomfort—Methotrexate—breast cancer	8.13e-06	0.000123	CcSEcCtD
Mitoxantrone—Leukopenia—Epirubicin—breast cancer	8.1e-06	0.000122	CcSEcCtD
Mitoxantrone—Back pain—Doxorubicin—breast cancer	8.1e-06	0.000122	CcSEcCtD
Mitoxantrone—Headache—Paclitaxel—breast cancer	8.09e-06	0.000122	CcSEcCtD
Mitoxantrone—Hypersensitivity—Docetaxel—breast cancer	8.07e-06	0.000122	CcSEcCtD
Mitoxantrone—Confusional state—Methotrexate—breast cancer	7.96e-06	0.00012	CcSEcCtD
Mitoxantrone—Cough—Epirubicin—breast cancer	7.9e-06	0.000119	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Methotrexate—breast cancer	7.89e-06	0.000119	CcSEcCtD
Mitoxantrone—Vision blurred—Doxorubicin—breast cancer	7.89e-06	0.000119	CcSEcCtD
Mitoxantrone—Asthenia—Docetaxel—breast cancer	7.86e-06	0.000119	CcSEcCtD
Mitoxantrone—Convulsion—Epirubicin—breast cancer	7.84e-06	0.000118	CcSEcCtD
Mitoxantrone—Infection—Methotrexate—breast cancer	7.84e-06	0.000118	CcSEcCtD
Mitoxantrone—Hypertension—Epirubicin—breast cancer	7.81e-06	0.000118	CcSEcCtD
Mitoxantrone—Hypersensitivity—Capecitabine—breast cancer	7.81e-06	0.000118	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Doxorubicin—breast cancer	7.77e-06	0.000117	CcSEcCtD
Mitoxantrone—Anaemia—Doxorubicin—breast cancer	7.74e-06	0.000117	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Methotrexate—breast cancer	7.73e-06	0.000117	CcSEcCtD
Mitoxantrone—Myalgia—Epirubicin—breast cancer	7.7e-06	0.000116	CcSEcCtD
Mitoxantrone—Arthralgia—Epirubicin—breast cancer	7.7e-06	0.000116	CcSEcCtD
Mitoxantrone—Chest pain—Epirubicin—breast cancer	7.7e-06	0.000116	CcSEcCtD
Mitoxantrone—Anxiety—Epirubicin—breast cancer	7.68e-06	0.000116	CcSEcCtD
Mitoxantrone—Nausea—Paclitaxel—breast cancer	7.67e-06	0.000116	CcSEcCtD
Mitoxantrone—Skin disorder—Methotrexate—breast cancer	7.66e-06	0.000116	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Methotrexate—breast cancer	7.63e-06	0.000115	CcSEcCtD
Mitoxantrone—Discomfort—Epirubicin—breast cancer	7.61e-06	0.000115	CcSEcCtD
Mitoxantrone—Asthenia—Capecitabine—breast cancer	7.61e-06	0.000115	CcSEcCtD
Mitoxantrone—Malaise—Doxorubicin—breast cancer	7.55e-06	0.000114	CcSEcCtD
Mitoxantrone—Anorexia—Methotrexate—breast cancer	7.52e-06	0.000114	CcSEcCtD
Mitoxantrone—Leukopenia—Doxorubicin—breast cancer	7.49e-06	0.000113	CcSEcCtD
Mitoxantrone—Diarrhoea—Docetaxel—breast cancer	7.49e-06	0.000113	CcSEcCtD
Mitoxantrone—Confusional state—Epirubicin—breast cancer	7.45e-06	0.000112	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Epirubicin—breast cancer	7.38e-06	0.000111	CcSEcCtD
Mitoxantrone—Oedema—Epirubicin—breast cancer	7.38e-06	0.000111	CcSEcCtD
Mitoxantrone—Hypotension—Methotrexate—breast cancer	7.37e-06	0.000111	CcSEcCtD
Mitoxantrone—Infection—Epirubicin—breast cancer	7.34e-06	0.000111	CcSEcCtD
Mitoxantrone—Cough—Doxorubicin—breast cancer	7.31e-06	0.00011	CcSEcCtD
Mitoxantrone—Shock—Epirubicin—breast cancer	7.27e-06	0.00011	CcSEcCtD
Mitoxantrone—Convulsion—Doxorubicin—breast cancer	7.25e-06	0.000109	CcSEcCtD
Mitoxantrone—Diarrhoea—Capecitabine—breast cancer	7.25e-06	0.000109	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Epirubicin—breast cancer	7.23e-06	0.000109	CcSEcCtD
Mitoxantrone—Hypertension—Doxorubicin—breast cancer	7.23e-06	0.000109	CcSEcCtD
Mitoxantrone—Tachycardia—Epirubicin—breast cancer	7.21e-06	0.000109	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Methotrexate—breast cancer	7.19e-06	0.000108	CcSEcCtD
Mitoxantrone—Skin disorder—Epirubicin—breast cancer	7.17e-06	0.000108	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Epirubicin—breast cancer	7.14e-06	0.000108	CcSEcCtD
Mitoxantrone—Chest pain—Doxorubicin—breast cancer	7.13e-06	0.000108	CcSEcCtD
Mitoxantrone—Myalgia—Doxorubicin—breast cancer	7.13e-06	0.000108	CcSEcCtD
Mitoxantrone—Arthralgia—Doxorubicin—breast cancer	7.13e-06	0.000108	CcSEcCtD
Mitoxantrone—Anxiety—Doxorubicin—breast cancer	7.1e-06	0.000107	CcSEcCtD
Mitoxantrone—Paraesthesia—Methotrexate—breast cancer	7.09e-06	0.000107	CcSEcCtD
Mitoxantrone—Discomfort—Doxorubicin—breast cancer	7.04e-06	0.000106	CcSEcCtD
Mitoxantrone—Anorexia—Epirubicin—breast cancer	7.04e-06	0.000106	CcSEcCtD
Mitoxantrone—Dyspnoea—Methotrexate—breast cancer	7.04e-06	0.000106	CcSEcCtD
Mitoxantrone—Somnolence—Methotrexate—breast cancer	7.02e-06	0.000106	CcSEcCtD
Mitoxantrone—Vomiting—Docetaxel—breast cancer	6.96e-06	0.000105	CcSEcCtD
Mitoxantrone—Dyspepsia—Methotrexate—breast cancer	6.95e-06	0.000105	CcSEcCtD
Mitoxantrone—Rash—Docetaxel—breast cancer	6.9e-06	0.000104	CcSEcCtD
Mitoxantrone—Hypotension—Epirubicin—breast cancer	6.9e-06	0.000104	CcSEcCtD
Mitoxantrone—Dermatitis—Docetaxel—breast cancer	6.9e-06	0.000104	CcSEcCtD
Mitoxantrone—Confusional state—Doxorubicin—breast cancer	6.89e-06	0.000104	CcSEcCtD
Mitoxantrone—Decreased appetite—Methotrexate—breast cancer	6.86e-06	0.000104	CcSEcCtD
Mitoxantrone—Headache—Docetaxel—breast cancer	6.86e-06	0.000103	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Doxorubicin—breast cancer	6.83e-06	0.000103	CcSEcCtD
Mitoxantrone—Oedema—Doxorubicin—breast cancer	6.83e-06	0.000103	CcSEcCtD
Mitoxantrone—Fatigue—Methotrexate—breast cancer	6.8e-06	0.000103	CcSEcCtD
Mitoxantrone—Infection—Doxorubicin—breast cancer	6.79e-06	0.000102	CcSEcCtD
Mitoxantrone—Pain—Methotrexate—breast cancer	6.75e-06	0.000102	CcSEcCtD
Mitoxantrone—Vomiting—Capecitabine—breast cancer	6.74e-06	0.000102	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Epirubicin—breast cancer	6.73e-06	0.000102	CcSEcCtD
Mitoxantrone—Shock—Doxorubicin—breast cancer	6.72e-06	0.000101	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Doxorubicin—breast cancer	6.69e-06	0.000101	CcSEcCtD
Mitoxantrone—Rash—Capecitabine—breast cancer	6.68e-06	0.000101	CcSEcCtD
Mitoxantrone—Dermatitis—Capecitabine—breast cancer	6.68e-06	0.000101	CcSEcCtD
Mitoxantrone—Tachycardia—Doxorubicin—breast cancer	6.67e-06	0.000101	CcSEcCtD
Mitoxantrone—Headache—Capecitabine—breast cancer	6.64e-06	0.0001	CcSEcCtD
Mitoxantrone—Skin disorder—Doxorubicin—breast cancer	6.64e-06	0.0001	CcSEcCtD
Mitoxantrone—Paraesthesia—Epirubicin—breast cancer	6.63e-06	0.0001	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Doxorubicin—breast cancer	6.61e-06	9.97e-05	CcSEcCtD
Mitoxantrone—Dyspnoea—Epirubicin—breast cancer	6.58e-06	9.93e-05	CcSEcCtD
Mitoxantrone—Somnolence—Epirubicin—breast cancer	6.57e-06	9.91e-05	CcSEcCtD
Mitoxantrone—Anorexia—Doxorubicin—breast cancer	6.51e-06	9.83e-05	CcSEcCtD
Mitoxantrone—Nausea—Docetaxel—breast cancer	6.5e-06	9.81e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Methotrexate—breast cancer	6.5e-06	9.81e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Epirubicin—breast cancer	6.5e-06	9.81e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Methotrexate—breast cancer	6.45e-06	9.74e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Epirubicin—breast cancer	6.42e-06	9.69e-05	CcSEcCtD
Mitoxantrone—Hypotension—Doxorubicin—breast cancer	6.38e-06	9.63e-05	CcSEcCtD
Mitoxantrone—Fatigue—Epirubicin—breast cancer	6.37e-06	9.61e-05	CcSEcCtD
Mitoxantrone—Pain—Epirubicin—breast cancer	6.32e-06	9.53e-05	CcSEcCtD
Mitoxantrone—Constipation—Epirubicin—breast cancer	6.32e-06	9.53e-05	CcSEcCtD
Mitoxantrone—Nausea—Capecitabine—breast cancer	6.3e-06	9.5e-05	CcSEcCtD
Mitoxantrone—Urticaria—Methotrexate—breast cancer	6.27e-06	9.46e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Methotrexate—breast cancer	6.24e-06	9.41e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Methotrexate—breast cancer	6.24e-06	9.41e-05	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.23e-06	9.39e-05	CcSEcCtD
Mitoxantrone—Paraesthesia—Doxorubicin—breast cancer	6.14e-06	9.26e-05	CcSEcCtD
Mitoxantrone—Dyspnoea—Doxorubicin—breast cancer	6.09e-06	9.19e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Epirubicin—breast cancer	6.09e-06	9.18e-05	CcSEcCtD
Mitoxantrone—Somnolence—Doxorubicin—breast cancer	6.07e-06	9.17e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Epirubicin—breast cancer	6.04e-06	9.11e-05	CcSEcCtD
Mitoxantrone—Dyspepsia—Doxorubicin—breast cancer	6.01e-06	9.08e-05	CcSEcCtD
Mitoxantrone—Decreased appetite—Doxorubicin—breast cancer	5.94e-06	8.96e-05	CcSEcCtD
Mitoxantrone—Fatigue—Doxorubicin—breast cancer	5.89e-06	8.89e-05	CcSEcCtD
Mitoxantrone—Urticaria—Epirubicin—breast cancer	5.87e-06	8.85e-05	CcSEcCtD
Mitoxantrone—Constipation—Doxorubicin—breast cancer	5.84e-06	8.82e-05	CcSEcCtD
Mitoxantrone—Pain—Doxorubicin—breast cancer	5.84e-06	8.82e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Epirubicin—breast cancer	5.84e-06	8.81e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Epirubicin—breast cancer	5.84e-06	8.81e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Methotrexate—breast cancer	5.81e-06	8.77e-05	CcSEcCtD
Mitoxantrone—Asthenia—Methotrexate—breast cancer	5.66e-06	8.54e-05	CcSEcCtD
Mitoxantrone—Feeling abnormal—Doxorubicin—breast cancer	5.63e-06	8.5e-05	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Doxorubicin—breast cancer	5.59e-06	8.43e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Epirubicin—breast cancer	5.44e-06	8.21e-05	CcSEcCtD
Mitoxantrone—Urticaria—Doxorubicin—breast cancer	5.43e-06	8.19e-05	CcSEcCtD
Mitoxantrone—Abdominal pain—Doxorubicin—breast cancer	5.4e-06	8.15e-05	CcSEcCtD
Mitoxantrone—Body temperature increased—Doxorubicin—breast cancer	5.4e-06	8.15e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Methotrexate—breast cancer	5.4e-06	8.15e-05	CcSEcCtD
Mitoxantrone—Asthenia—Epirubicin—breast cancer	5.3e-06	7.99e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Epirubicin—breast cancer	5.05e-06	7.62e-05	CcSEcCtD
Mitoxantrone—Hypersensitivity—Doxorubicin—breast cancer	5.03e-06	7.6e-05	CcSEcCtD
Mitoxantrone—Vomiting—Methotrexate—breast cancer	5.02e-06	7.57e-05	CcSEcCtD
Mitoxantrone—Rash—Methotrexate—breast cancer	4.98e-06	7.51e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Methotrexate—breast cancer	4.97e-06	7.5e-05	CcSEcCtD
Mitoxantrone—Headache—Methotrexate—breast cancer	4.94e-06	7.46e-05	CcSEcCtD
Mitoxantrone—Asthenia—Doxorubicin—breast cancer	4.9e-06	7.4e-05	CcSEcCtD
Mitoxantrone—Vomiting—Epirubicin—breast cancer	4.7e-06	7.08e-05	CcSEcCtD
Mitoxantrone—Nausea—Methotrexate—breast cancer	4.69e-06	7.07e-05	CcSEcCtD
Mitoxantrone—Diarrhoea—Doxorubicin—breast cancer	4.68e-06	7.05e-05	CcSEcCtD
Mitoxantrone—Rash—Epirubicin—breast cancer	4.66e-06	7.03e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Epirubicin—breast cancer	4.65e-06	7.02e-05	CcSEcCtD
Mitoxantrone—Headache—Epirubicin—breast cancer	4.63e-06	6.98e-05	CcSEcCtD
Mitoxantrone—Nausea—Epirubicin—breast cancer	4.39e-06	6.62e-05	CcSEcCtD
Mitoxantrone—Vomiting—Doxorubicin—breast cancer	4.34e-06	6.56e-05	CcSEcCtD
Mitoxantrone—Rash—Doxorubicin—breast cancer	4.31e-06	6.5e-05	CcSEcCtD
Mitoxantrone—Dermatitis—Doxorubicin—breast cancer	4.3e-06	6.49e-05	CcSEcCtD
Mitoxantrone—Headache—Doxorubicin—breast cancer	4.28e-06	6.46e-05	CcSEcCtD
Mitoxantrone—Nausea—Doxorubicin—breast cancer	4.06e-06	6.12e-05	CcSEcCtD
Mitoxantrone—CYP1B1—Metabolism—GPX1—breast cancer	1.34e-06	3.25e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HRAS—breast cancer	1.34e-06	3.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—APRT—breast cancer	1.33e-06	3.23e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP1A1—breast cancer	1.33e-06	3.22e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—breast cancer	1.33e-06	3.21e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP2D6—breast cancer	1.32e-06	3.2e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ERCC2—breast cancer	1.32e-06	3.19e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOTCH1—breast cancer	1.31e-06	3.18e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ABCB1—breast cancer	1.31e-06	3.18e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NCOA2—breast cancer	1.3e-06	3.14e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMS—breast cancer	1.29e-06	3.12e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.29e-06	3.11e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—APC—breast cancer	1.28e-06	3.11e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KIT—breast cancer	1.28e-06	3.11e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—breast cancer	1.28e-06	3.1e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—breast cancer	1.28e-06	3.1e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PLA2G4A—breast cancer	1.28e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NCOR1—breast cancer	1.28e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GSTM1—breast cancer	1.28e-06	3.09e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGF—breast cancer	1.27e-06	3.08e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—FASN—breast cancer	1.26e-06	3.05e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ESRRA—breast cancer	1.25e-06	3.04e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.25e-06	3.04e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—BCHE—breast cancer	1.25e-06	3.03e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.24e-06	3.01e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—breast cancer	1.24e-06	3e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC5A5—breast cancer	1.24e-06	3e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MED12—breast cancer	1.22e-06	2.96e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DPYD—breast cancer	1.22e-06	2.96e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GPX1—breast cancer	1.22e-06	2.96e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1A1—breast cancer	1.21e-06	2.93e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—BRAF—breast cancer	1.21e-06	2.92e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALDOA—breast cancer	1.2e-06	2.92e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ERCC2—breast cancer	1.2e-06	2.9e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A1—breast cancer	1.19e-06	2.89e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NQO1—breast cancer	1.19e-06	2.89e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HADHB—breast cancer	1.19e-06	2.88e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPI—breast cancer	1.19e-06	2.88e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CAV1—breast cancer	1.18e-06	2.86e-05	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT1—breast cancer	1.18e-06	2.86e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT2—breast cancer	1.18e-06	2.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOA3—breast cancer	1.17e-06	2.83e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP3A4—breast cancer	1.16e-06	2.82e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A2—breast cancer	1.16e-06	2.81e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1B1—breast cancer	1.15e-06	2.77e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CAV1—breast cancer	1.14e-06	2.77e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CPT1A—breast cancer	1.14e-06	2.76e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTR—breast cancer	1.14e-06	2.76e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ABCG2—breast cancer	1.14e-06	2.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.13e-06	2.75e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.13e-06	2.75e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CD—breast cancer	1.13e-06	2.74e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.13e-06	2.73e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—breast cancer	1.13e-06	2.73e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HSP90AA1—breast cancer	1.12e-06	2.72e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SERPINE1—breast cancer	1.12e-06	2.71e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HPGDS—breast cancer	1.12e-06	2.7e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HBA1—breast cancer	1.11e-06	2.69e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NCOA1—breast cancer	1.09e-06	2.65e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.09e-06	2.64e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ADSL—breast cancer	1.09e-06	2.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PHGDH—breast cancer	1.09e-06	2.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—UMPS—breast cancer	1.09e-06	2.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FHL2—breast cancer	1.09e-06	2.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NME1—breast cancer	1.09e-06	2.63e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTT1—breast cancer	1.08e-06	2.62e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ACHE—breast cancer	1.08e-06	2.62e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—STK11—breast cancer	1.08e-06	2.61e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP19A1—breast cancer	1.08e-06	2.61e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CG—breast cancer	1.08e-06	2.61e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BRIP1—breast cancer	1.07e-06	2.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LDHB—breast cancer	1.07e-06	2.58e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HPSE—breast cancer	1.07e-06	2.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—breast cancer	1.07e-06	2.58e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.05e-06	2.54e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CG—breast cancer	1.04e-06	2.52e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CAV1—breast cancer	1.04e-06	2.52e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP17A1—breast cancer	1.02e-06	2.48e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ENO1—breast cancer	1.01e-06	2.46e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS1—breast cancer	1.01e-06	2.46e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MDM2—breast cancer	1.01e-06	2.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCC1—breast cancer	1.01e-06	2.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA3—breast cancer	1.01e-06	2.45e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMMR—breast cancer	1.01e-06	2.45e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RAF1—breast cancer	1.01e-06	2.44e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—COMT—breast cancer	1e-06	2.42e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ERBB2—breast cancer	9.98e-07	2.42e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTP1—breast cancer	9.96e-07	2.41e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP2D6—breast cancer	9.95e-07	2.41e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTOR—breast cancer	9.85e-07	2.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CB—breast cancer	9.85e-07	2.38e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—breast cancer	9.83e-07	2.38e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMOX1—breast cancer	9.83e-07	2.38e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ITPR1—breast cancer	9.8e-07	2.37e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARGC1B—breast cancer	9.8e-07	2.37e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOA2—breast cancer	9.76e-07	2.36e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTGS2—breast cancer	9.75e-07	2.36e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	9.48e-07	2.3e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—FASN—breast cancer	9.47e-07	2.29e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CG—breast cancer	9.47e-07	2.29e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CD—breast cancer	9.46e-07	2.29e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ABCB1—breast cancer	9.43e-07	2.28e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—BCHE—breast cancer	9.43e-07	2.28e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—ALB—breast cancer	9.34e-07	2.26e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC5A5—breast cancer	9.31e-07	2.26e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMS—breast cancer	9.26e-07	2.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA4—breast cancer	9.25e-07	2.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CA9—breast cancer	9.25e-07	2.24e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1B—breast cancer	9.24e-07	2.24e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PLA2G4A—breast cancer	9.15e-07	2.22e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NCOR1—breast cancer	9.15e-07	2.22e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GSTM1—breast cancer	9.15e-07	2.22e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CD—breast cancer	9.15e-07	2.22e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—ALB—breast cancer	9.03e-07	2.19e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA2—breast cancer	9.01e-07	2.18e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX2—breast cancer	9.01e-07	2.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A1—breast cancer	8.99e-07	2.18e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NQO1—breast cancer	8.99e-07	2.18e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—breast cancer	8.93e-07	2.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX4—breast cancer	8.9e-07	2.16e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SULT1A1—breast cancer	8.9e-07	2.16e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP3A4—breast cancer	8.77e-07	2.12e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GPX1—breast cancer	8.77e-07	2.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CTNNB1—breast cancer	8.73e-07	2.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTA1—breast cancer	8.7e-07	2.11e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—IDH1—breast cancer	8.7e-07	2.11e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A1—breast cancer	8.68e-07	2.1e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—breast cancer	8.64e-07	2.09e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1B1—breast cancer	8.62e-07	2.09e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ERCC2—breast cancer	8.61e-07	2.08e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NAT2—breast cancer	8.6e-07	2.08e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	8.58e-07	2.08e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CDKN1A—breast cancer	8.53e-07	2.07e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PTEN—breast cancer	8.51e-07	2.06e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HSP90AA1—breast cancer	8.46e-07	2.05e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CD—breast cancer	8.32e-07	2.02e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CB—breast cancer	8.24e-07	2e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOA1—breast cancer	8.23e-07	1.99e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—ALB—breast cancer	8.22e-07	1.99e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTGS2—breast cancer	8.17e-07	1.98e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP19A1—breast cancer	8.11e-07	1.96e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—STK11—breast cancer	8.11e-07	1.96e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—breast cancer	8.09e-07	1.96e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CB—breast cancer	7.97e-07	1.93e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTGS2—breast cancer	7.9e-07	1.91e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SRC—breast cancer	7.89e-07	1.91e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—breast cancer	7.86e-07	1.9e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—STAT3—breast cancer	7.61e-07	1.84e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DPYD—breast cancer	7.54e-07	1.83e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MED12—breast cancer	7.54e-07	1.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—COMT—breast cancer	7.54e-07	1.83e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTP1—breast cancer	7.5e-07	1.82e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CAV1—breast cancer	7.46e-07	1.81e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALDOA—breast cancer	7.42e-07	1.8e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMOX1—breast cancer	7.4e-07	1.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ITPR1—breast cancer	7.38e-07	1.79e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MAPK3—breast cancer	7.27e-07	1.76e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CB—breast cancer	7.26e-07	1.76e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOA3—breast cancer	7.21e-07	1.75e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTGS2—breast cancer	7.19e-07	1.74e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A2—breast cancer	7.16e-07	1.73e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PTEN—breast cancer	7.12e-07	1.73e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—breast cancer	7.07e-07	1.71e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TGFB1—breast cancer	7.05e-07	1.71e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCG2—breast cancer	7.01e-07	1.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTR—breast cancer	7.01e-07	1.7e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CPT1A—breast cancer	7.01e-07	1.7e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMS—breast cancer	6.97e-07	1.69e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—EGFR—breast cancer	6.91e-07	1.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GSTM1—breast cancer	6.89e-07	1.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PLA2G4A—breast cancer	6.89e-07	1.67e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOR1—breast cancer	6.89e-07	1.67e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PTEN—breast cancer	6.89e-07	1.67e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HPGDS—breast cancer	6.88e-07	1.67e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HBA1—breast cancer	6.83e-07	1.65e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CG—breast cancer	6.8e-07	1.65e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTT1—breast cancer	6.67e-07	1.61e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ACHE—breast cancer	6.67e-07	1.61e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GPX1—breast cancer	6.6e-07	1.6e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A1—breast cancer	6.54e-07	1.58e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—KRAS—breast cancer	6.53e-07	1.58e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ERCC2—breast cancer	6.48e-07	1.57e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP17A1—breast cancer	6.31e-07	1.53e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PTEN—breast cancer	6.27e-07	1.52e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ENO1—breast cancer	6.25e-07	1.51e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS1—breast cancer	6.25e-07	1.51e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP2D6—breast cancer	6.13e-07	1.48e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—breast cancer	6.09e-07	1.48e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOA2—breast cancer	6.01e-07	1.46e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PIK3CA—breast cancer	6e-07	1.45e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CD—breast cancer	5.98e-07	1.45e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ALB—breast cancer	5.9e-07	1.43e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—FASN—breast cancer	5.83e-07	1.41e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—BCHE—breast cancer	5.81e-07	1.41e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC5A5—breast cancer	5.74e-07	1.39e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—breast cancer	5.64e-07	1.37e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CAV1—breast cancer	5.62e-07	1.36e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HRAS—breast cancer	5.55e-07	1.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A1—breast cancer	5.54e-07	1.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NQO1—breast cancer	5.54e-07	1.34e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—breast cancer	5.31e-07	1.29e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1B1—breast cancer	5.31e-07	1.29e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSP90AA1—breast cancer	5.21e-07	1.26e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CB—breast cancer	5.21e-07	1.26e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTGS2—breast cancer	5.16e-07	1.25e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CG—breast cancer	5.12e-07	1.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOA1—breast cancer	5.07e-07	1.23e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PIK3CA—breast cancer	5.03e-07	1.22e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STK11—breast cancer	5e-07	1.21e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP19A1—breast cancer	5e-07	1.21e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT1—breast cancer	4.9e-07	1.19e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PIK3CA—breast cancer	4.86e-07	1.18e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—COMT—breast cancer	4.64e-07	1.12e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTP1—breast cancer	4.62e-07	1.12e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMOX1—breast cancer	4.56e-07	1.1e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ITPR1—breast cancer	4.55e-07	1.1e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PTEN—breast cancer	4.5e-07	1.09e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CD—breast cancer	4.5e-07	1.09e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ALB—breast cancer	4.44e-07	1.08e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PIK3CA—breast cancer	4.42e-07	1.07e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ABCB1—breast cancer	4.38e-07	1.06e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMS—breast cancer	4.3e-07	1.04e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—breast cancer	4.25e-07	1.03e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOR1—breast cancer	4.25e-07	1.03e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PLA2G4A—breast cancer	4.25e-07	1.03e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GSTM1—breast cancer	4.25e-07	1.03e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKT1—breast cancer	4.11e-07	9.94e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GPX1—breast cancer	4.07e-07	9.85e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A1—breast cancer	4.03e-07	9.75e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ERCC2—breast cancer	3.99e-07	9.67e-06	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKT1—breast cancer	3.97e-07	9.62e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CB—breast cancer	3.92e-07	9.5e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTGS2—breast cancer	3.89e-07	9.41e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—breast cancer	3.75e-07	9.09e-06	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKT1—breast cancer	3.61e-07	8.75e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CAV1—breast cancer	3.46e-07	8.39e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PTEN—breast cancer	3.39e-07	8.21e-06	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PIK3CA—breast cancer	3.18e-07	7.69e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CG—breast cancer	3.15e-07	7.64e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CD—breast cancer	2.77e-07	6.71e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ALB—breast cancer	2.74e-07	6.63e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—breast cancer	2.62e-07	6.34e-06	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKT1—breast cancer	2.59e-07	6.28e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CB—breast cancer	2.42e-07	5.85e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTGS2—breast cancer	2.39e-07	5.8e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PIK3CA—breast cancer	2.39e-07	5.79e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PTEN—breast cancer	2.09e-07	5.06e-06	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKT1—breast cancer	1.95e-07	4.73e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PIK3CA—breast cancer	1.47e-07	3.57e-06	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKT1—breast cancer	1.2e-07	2.91e-06	CbGpPWpGaD
